WallStSmart

JPMorgan Chase & Co (JPM)vsSentage Holdings Inc (SNTG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JPMorgan Chase & Co generates 270393177% more annual revenue ($186.33B vs $68,910). JPM leads profitability with a 34.9% profit margin vs 0.0%. JPM earns a higher WallStSmart Score of 81/100 (A-).

JPM

Exceptional Buy

81

out of 100

Grade: A-

Growth: 10.0Profit: 8.0Value: 5.7Quality: 3.0
Piotroski: 4/9Altman Z: 0.55

SNTG

Avoid

21

out of 100

Grade: F

Growth: 2.0Profit: 2.5Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: -5.07

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JPM6 strengths · Avg: 9.3/10
Market CapQuality
$916.31B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
34.9%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
50.4%10/10

Strong operational efficiency at 50.4%

Revenue GrowthGrowth
30.4%10/10

Revenue surging 30.4% year-over-year

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

SNTG2 strengths · Avg: 9.5/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

Areas to Watch

JPM4 concerns · Avg: 2.3/10
PEG RatioValuation
1.724/10

Expensive relative to growth rate

Free Cash FlowQuality
$-211.76B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.552/10

Distress zone — elevated risk

Debt/EquityHealth
3.301/10

Elevated debt levels

SNTG4 concerns · Avg: 2.8/10
Market CapQuality
$4.66M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-54.3%2/10

ROE of -54.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : JPM

The strongest argument for JPM centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 34.9% and operating margin at 50.4%. Revenue growth of 30.4% demonstrates continued momentum.

Bull Case : SNTG

The strongest argument for SNTG centers on Price/Book, Debt/Equity.

Bear Case : JPM

The primary concerns for JPM are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.30 is elevated, increasing financial risk.

Bear Case : SNTG

The primary concerns for SNTG are Market Cap, Profit Margin, Piotroski F-Score.

Key Dynamics to Monitor

JPM profiles as a growth stock while SNTG is a value play — different risk/reward profiles.

SNTG carries more volatility with a beta of 2.38 — expect wider price swings.

JPM is growing revenue faster at 30.4% — sustainability is the question.

SNTG generates stronger free cash flow (-475,908), providing more financial flexibility.

Bottom Line

JPM scores higher overall (81/100 vs 21/100), backed by strong 34.9% margins and 30.4% revenue growth. Both earn "Exceptional Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JPMorgan Chase & Co

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

JPMorgan Chase & Co. is an American multinational investment bank and financial services holding company headquartered in New York City. JPMorgan Chase is incorporated in Delaware. As a Bulge Bracket bank, it is a major provider of various investment banking and financial services. It is one of America's Big Four banks, along with Bank of America, Citigroup, and Wells Fargo. JPMorgan Chase is considered to be a universal bank and a custodian bank. The J.P. Morgan brand is used by the investment banking, asset management, private banking, private wealth management, and treasury services divisions.

Visit Website →

Sentage Holdings Inc

FINANCIAL SERVICES · CREDIT SERVICES · China

Sentage Holdings Inc (SNTG) is a forward-thinking technology firm poised to revolutionize the healthcare sector through cutting-edge data analytics and digital health solutions. With a commitment to enhancing patient outcomes and operational efficiencies for healthcare providers, Sentage is carving out a vital role in the burgeoning health informatics landscape. The company’s strategic focus on delivering actionable insights and its plans for product expansion underscore its potential for substantial growth, generating value for investors while driving transformative improvements in healthcare delivery.

Visit Website →

Want to dig deeper into these stocks?